Related Experiment Video
Updated: Nov 29, 2025

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Published on: October 25, 2019
β-Adrenoceptor blockade prevents carotid body hyperactivity and elevated vascular sympathetic nerve density induced
Abdulaziz A Alzahrani1,2, Lily L Cao1,3, Hayyaf S Aldossary1,4
1Institute of Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Insights
Beta-blocker treatment with propranolol prevented carotid body (CB) hyperactivity, sympathetic nerve growth, and hypertension caused by chronic intermittent hypoxia (CIH). This highlights a new role for beta-adrenergic stimulation in CIH-induced cardiovascular changes.
Area of Science:
- Cardiovascular Physiology
- Neuroendocrinology
- Respiratory Physiology
Background:
- Carotid body (CB) hyperactivity contributes to hypertension during chronic intermittent hypoxia (CIH).
- Adrenaline is elevated in CIH and may activate the CB, but chronic adrenergic stimulation's role is unclear.
- Beta-adrenergic receptors (β1 and β2) are present on CB type I cells.
Purpose of the Study:
- To investigate if propranolol (a beta-blocker) prevents CB hyperactivity, vascular sympathetic nerve growth, and hypertension induced by CIH.
- To determine the role of chronic beta-adrenergic stimulation in mediating CB hyperactivity.
Main Methods:
- Adult male Wistar rats were divided into Control, Control+Propranolol, CIH, and CIH+Propranolol groups.
- CIH was induced for 3 weeks (8 cycles/hr, 8 hrs/day).
- Propranolol was administered (40 mg/kg/day) via drinking water; immunohistochemistry and physiological measurements were performed.
Main Results:
- CIH increased basal CB chemoafferent activity 2-3 fold, which was prevented by propranolol.
- Propranolol attenuated chemoafferent responses to hypoxia and mitochondrial inhibitors, especially in CIH animals.
- Propranolol reduced respiratory frequency, abolished CIH-induced increases in vascular sympathetic nerve density, and altered blood pressure responses during hypoxia.
Conclusions:
- Chronic beta-adrenergic stimulation plays a significant role in CB hyperactivity, sympathetic vascular hyperinnervation, and altered blood pressure control during CIH.
- Propranolol treatment effectively mitigated key pathological changes induced by CIH.
- These findings identify novel mechanisms involving beta-adrenergic pathways in the cardiovascular consequences of CIH.
Abstract:
Carotid body (CB) hyperactivity promotes hypertension in response to chronic intermittent hypoxia (CIH). The plasma concentration of adrenaline is reported to be elevated in CIH and our previous work suggests that adrenaline directly activates the CB. However, a role for chronic adrenergic stimulation in mediating CB hyperactivity is currently unknown. This study evaluated whether beta-blocker treatment with propranolol (Prop) prevented the development of CB hyperactivity, vascular sympathetic nerve growth and hypertension caused by CIH. Adult male Wistar rats were assigned into 1 of 4 groups: Control (N), N + Prop, CIH and CIH + Prop. The CIH paradigm consisted of 8 cycles h-1, 8 h day-1, for 3 weeks. Propranolol was administered via drinking water to achieve a dose of 40 mg kg-1 day-1. Immunohistochemistry revealed the presence of both β1 and β2-adrenoceptor subtypes on the CB type I cell. CIH caused a 2-3-fold elevation in basal CB single-fibre chemoafferent activity and this was prevented by chronic propranolol treatment. Chemoafferent responses to hypoxia and mitochondrial inhibitors were attenuated by propranolol, an effect that was greater in CIH animals. Propranolol decreased respiratory frequency in normoxia and hypoxia in N and CIH. Propranolol also abolished the CIH mediated increase in vascular sympathetic nerve density. Arterial blood pressure was reduced in propranolol groups during hypoxia. Propranolol exaggerated the fall in blood pressure in most (6/7) CIH animals during hypoxia, suggestive of reduced sympathetic tone. These findings therefore identify new roles for β-adrenergic stimulation in evoking CB hyperactivity, sympathetic vascular hyperinnervation and altered blood pressure control in response to CIH.
More Related Videos
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antihypertensive Drugs: Action of β1 Blockers

